Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Anika Therapeutics, Inc. (ANIK)

23.25   0.39 (1.71%) 08-19 01:59
Open: 23.08 Pre. Close: 22.86
High: 23.545 Low: 22.73
Volume: 44,073 Market Cap: 339(M)
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 23.44 - 23.56 23.56 - 23.65
Low: 22.52 - 22.65 22.65 - 22.74
Close: 22.66 - 22.87 22.87 - 23.03

Technical analysis

as of: 2022-08-18 3:50:46 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 29.44     One year: 34.39
Support: Support1: 22.97    Support2: 21.6
Resistance: Resistance1: 25.2    Resistance2: 29.44
Pivot: 23.11
Moving Average: MA(5): 22.92     MA(20): 23.11
MA(100): 22.54     MA(250): 30.78
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 43.4     %D(3): 37
RSI: RSI(14): 54.3
52-week: High: 45.81  Low: 19.95
Average Vol(K): 3-Month: 106 (K)  10-Days: 76 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ANIK ] has closed below upper band by 35.4%. Bollinger Bands are 9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 18 Aug 2022
Prime Time Action - August 18, 2022, Hour 1 - VSiN

Thu, 18 Aug 2022
Jon Anik: Kamaru Usman ‘absolutely not’ overlooking Leon Edwards despite light heavyweight talk - MMA Fighting

Thu, 18 Aug 2022
Aparajito: Anik Duttas homage to Satyajit Ray, set for digital premiere - News9 LIVE

Thu, 18 Aug 2022
Anik Dutta's 'Aparajito' set for digital premiere on ZEE5 - The Week

Mon, 15 Aug 2022
Hackers prove it doesn’t take much to hijack a dead satellite - Popular Science

Sun, 14 Aug 2022
Anika Therapeutics, Inc. (NASDAQ:ANIK) Holdings Cut by Los Angeles Capital Management LLC - Defense World

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 15 (M)
Shares Float 13 (M)
% Held by Insiders 1.9 (%)
% Held by Institutions 92.4 (%)
Shares Short 1,050 (K)
Shares Short P.Month 1,140 (K)

Stock Financials

EPS -0.12
EPS Est Next Qtl 0.36
EPS Est This Year 2.04
EPS Est Next Year 1.92
Book Value (p.s.) 19.65
Profit Margin (%) -7.3
Operating Margin (%) -8.4
Return on Assets (ttm) -2.3
Return on Equity (ttm) -3.9
Qtrly Rev. Growth 4
Gross Profit (p.s.) 6.31
Sales Per Share 10.43
EBITDA (p.s.) 0.12
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -196.01
PEG Ratio -3.3
Price to Book value 1.19
Price to Sales 2.25
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.